BRIGHT MINDS BIOSCIENCES INC: PHASE 2 CLINICAL TRIAL EVALUATING BMB-101 STUDY MET PRIMARY EFFICACY ENDPOINTS IN BOTH COHORTS

Reuters · 3d ago

Please log in to view news